
Galaxy India Pharma Private Limited
Founded in 2013 and headquartered in Maharashtra, India.
Founded in 2013 and headquartered in Maharashtra, India.
Thane, Maharashtra, India
+91-XXXXXXXXXX
-
U51101MH2013PTC247836
247836
Private Limited Indian Non-Government Company
03 Sep 2013
-
-
Unlisted
Roc-Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Akhilesh Barai ![]() | Director | 03-Sep-2013 | Current |
Chandraprakash Upadhyay ![]() | Director | 03-Sep-2013 | Current |
Vinod Pandey ![]() | Director | 03-Sep-2013 | Current |
Enhance accessibility to Galaxy India Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Galaxy India Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Galaxy India Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Galaxy India Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Galaxy India Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Akhilesh Harishchandra Barai was appointed as a Director was appointed as a Director on 03 Sep 2013 & has been associated with this company since 11 years 5 months .
03 Sep 2013
Chandraprakash Ramapati Upadhyay was appointed as a Director was appointed as a Director on 03 Sep 2013 & has been associated with this company since 11 years 5 months .
03 Sep 2013
Vinod Kumar Ashutosh Pandey was appointed as a Director was appointed as a Director on 03 Sep 2013 & has been associated with this company since 11 years 5 months .
03 Sep 2013
Galaxy India Pharma Private Limited was registered on 03 Sep 2013 with RoC-Mumbai & aged 11 years 5 months as per MCA records.
03 Sep 2013
Galaxy India Pharma Private Limited was incorporated on 03 Sep 2013.
The authorized share capital of Galaxy India Pharma Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 3 directors are associated with Galaxy India Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Galaxy India Pharma Private Limited is Shop No. 4 Ground Floor Shewtambari Apartment Chs, Bhatwadi Kisan Nagar No. 3 Wagle Estate Thane(W), Maharashtra, India, 400604.
The corporate identification number (CIN) of Galaxy India Pharma Private Limited is U51101MH2013PTC247836 and the company number is 247836 as per Ministry of Corporate Affairs (MCA).